Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10293405" target="_blank" >RIV/00216208:11110/14:10293405 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064203:_____/14:10293405
Výsledek na webu
<a href="http://dx.doi.org/10.1093/ejcts/ezt649" target="_blank" >http://dx.doi.org/10.1093/ejcts/ezt649</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/ejcts/ezt649" target="_blank" >10.1093/ejcts/ezt649</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database
Popis výsledku v původním jazyce
A retrospective database was developed by the European Society of Thoracic Surgeons, collecting patients submitted to surgery for thymic tumours to analyse clinico-pathological prognostic predictors. A total of 2151 incident cases from 35 institutions were collected from 1990 to 2010. Clinical-pathological characteristics were analysed, including age, gender, associated myasthenia gravis stage (Masaoka), World Health Organization histology, type of thymic tumour [thymoma, thymic carcinoma (TC), neuroendocrine thymic tumour (NETT)], type of resection (complete/incomplete), tumour size, adjuvant therapy and recurrence. Primary outcome was overall survival (OS); secondary outcomes were the proportion of incomplete resections, disease-free survival and thecumulative incidence of recurrence (CIR). A total of 2030 patients were analysed for OS (1798 thymomas, 191 TCs and 41 NETTs). Ten-year OS was 0.73 (95% confidence interval 0.69-0.75). Complete resection (R0) was achieved in 88% of the p
Název v anglickém jazyce
Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database
Popis výsledku anglicky
A retrospective database was developed by the European Society of Thoracic Surgeons, collecting patients submitted to surgery for thymic tumours to analyse clinico-pathological prognostic predictors. A total of 2151 incident cases from 35 institutions were collected from 1990 to 2010. Clinical-pathological characteristics were analysed, including age, gender, associated myasthenia gravis stage (Masaoka), World Health Organization histology, type of thymic tumour [thymoma, thymic carcinoma (TC), neuroendocrine thymic tumour (NETT)], type of resection (complete/incomplete), tumour size, adjuvant therapy and recurrence. Primary outcome was overall survival (OS); secondary outcomes were the proportion of incomplete resections, disease-free survival and thecumulative incidence of recurrence (CIR). A total of 2030 patients were analysed for OS (1798 thymomas, 191 TCs and 41 NETTs). Ten-year OS was 0.73 (95% confidence interval 0.69-0.75). Complete resection (R0) was achieved in 88% of the p
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
European Journal of Cardio-thoracic Surgery
ISSN
1010-7940
e-ISSN
—
Svazek periodika
46
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
8
Strana od-do
361-368
Kód UT WoS článku
000344968400007
EID výsledku v databázi Scopus
—